PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Laboratory Medicine, Yale School of Medicinegrid.471390.8, New Haven, Connecticut, USA.\', \'Department of Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio, USA.\', \'Department of Pathology and Laboratory Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA.\', \'Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah, USA.\', \'Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.\', \'Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.\', \'Department of Pathology and Laboratory Medicine, Medical University of South Carolinagrid.259828.c, Charleston, South Carolina, USA.\', \'Florida Department of Healthgrid.410382.c, Bureau of Public Health Laboratories, Jacksonville, Florida, USA.\', \'Department of Pathology, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.\', \'Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.\', \'Department of Laboratory Medicine and Pathology, Mayo Clinicgrid.66875.3a, Rochester, Minnesota, USA.\', \'Department of Pathology and Laboratory Medicine, University of Vermont Medical Centergrid.414924.e, Burlington, Vermont, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1128/JCM.01167-21
?:hasPublicationType
?:journal
  • Journal of clinical microbiology
is ?:pmid of
?:pmid
?:pmid
  • 34260276
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.256
?:rankingScore_hIndex
  • 226
?:title
  • Considerations from the College of American Pathologists for Implementation of an Assay for SARS-CoV-2 Testing after a Change in Regulatory Status.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all